LEHI, Utah, April 23, 2013 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq:NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today announced the appointment of Matthew Tripp, Ph.D., as Chief Scientific Officer. Dr. Tripp has extensive senior level R&D experience in consumer product manufacturing for major consumer goods companies, and will play a significant role in the development, manufacturing and quality control of Nature's Sunshine Product's broad range of nutritional products.
Since 2000, Dr. Tripp has served as Vice President, Research and Development, at Metagenics, a leading developer, manufacturer and distributor of high quality dietary supplements and medical foods sold through health care practitioners in the U.S. and pharmacies abroad. He has also concurrently served as Senior Vice President, Research and Development, at KinDex Therapeutics, a biotechnology company created by Metagenics. At Metagenics, he had direct responsibility for managing the discovery, development, safety, and clinical validation of medical foods and nutraceuticals. He played the leadership role of installing a new product development process that accelerated time to market and the volume of science based, clinically tested new products moving through the product pipeline. Significantly, Dr. Tripp led the creation of a substantial body of proprietary intellectual property, resulting in over 100 patents and patent applications.
Prior to working at Metagenics, he worked in progressively more responsible R&D and leadership roles at the Kellogg Company and Miller Brewing Company. Dr. Tripp received his Ph.D. from Washington State University in Physiology/Microbial Genetics/Microbiology; an M.A. in Microbial Physiology/Bacterial Genetics and a B.S. in Biology both from Western Michigan University. He also completed extensive post-doctoral research at the University of California – San Diego where he discovered novel protein phosphorylation cascades involved in nutrient signaling (nutrigenomics) – processes that when disrupted by poor diet, lead to metabolic disease and chronic illness.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts